Beam Therapeutics (BEAM) stock: insider trades, news & valuation
Heavy sellingShare price and insider trades
Beam Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 7 sold $18.6M of BEAM stock on the open market.
Get emailed when insiders cluster-buy stocks like BEAM
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
BEAM insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | $5K | 1 |
| Q3 2026 | — | 0 | $429K | 1 |
| Q2 2026 | — | 0 | $13.2M | 12 |
| Q1 2026 | — | 0 | $4.7M | 13 |
| Q4 2025 | — | 0 | $1.5M | 7 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 Beam Therapeutics Inc. insiders reported open-market purchases totaling $0, while 7 insiders reported sales totaling $18.6M. 31 of 34 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Oct 2SEC | Bethany J CavanaghSvp, Finance And Treasurer | Sell Plan | 18750,984 held (−0%) | $24.41 | $5K | +5.3% | — |
| Jul 29SEC | Amy SimonChief Medical Officer | Sell Plan | 16,66785,696 held (−16%) | $25.74 | $429K | -0.2% | — |
| Jul 2SEC | Amy SimonChief Medical Officer | Sell Plan | 373102,363 held (−0%) | $34.73 | $13K | -26.0% | — |
| Jul 1SEC | John M. EvansCEO | Sell Plan | 23,1001,049,105 held (−2%) | $34.26 | $791K | -25.0% | — |
| Jul 1SEC | John M. EvansCEO | Sell Plan | 13,4211,058,784 held (−1%) | $35.13 | $471K | -26.8% | — |
| Jul 1SEC | John M. EvansCEO | Sell Plan | 11,5791,047,205 held (−1%) | $35.91 | $416K | -28.4% | — |
| Jul 1SEC | John M. EvansCEO | Sell Plan | 1,9001,047,205 held (−0%) | $34.84 | $66K | -26.2% | — |
| Jun 29SEC | Fmr LlcSee Remark 1 | Sell | 251,488854,583 held (−23%) | $35.26 | $8.9M | -27.1% | — |
| Jun 29SEC | Fmr LlcSee Remark 1 | Sell | 33,3721,106,071 held (−3%) | $35.12 | $1.2M | -26.8% | — |
| Apr 6SEC | John M. EvansCEO | Sell Plan | 30,0781,047,205 held (−3%) | $24.58 | $739K | +4.6% | — |
| Apr 6SEC | Giuseppe CiaramellaPresident | Sell Plan | 11,810218,406 held (−5%) | $24.58 | $290K | +4.6% | — |
| Apr 6SEC | Amy SimonChief Medical Officer | Sell Plan | 6,700102,735 held (−6%) | $24.58 | $165K | +4.6% | — |
| Apr 6SEC | Christine BellonGeneral Counsel | Sell Plan | 5,956109,711 held (−5%) | $24.58 | $146K | +4.6% | — |
| Apr 6SEC | Bethany J CavanaghSvp, Finance And Treasurer | Sell Plan | 3,24251,171 held (−6%) | $24.58 | $80K | +4.6% | — |
| Apr 1SEC | John M. EvansCEO | Sell Plan | 25,000986,667 held (−2%) | $22.76 | $569K | +12.9% | — |
| Apr 1SEC | John M. EvansCEO | Sell Plan | 25,000986,667 held (−2%) | $22.37 | $559K | +14.9% | — |
| Feb 26SEC | Giuseppe CiaramellaPresident | Sell Plan | 35,000190,216 held (−16%) | $32.00 | $1.1M | -19.7% | — |
| Feb 2SEC | John M. EvansCEO | Sell Plan | 22,094989,573 held (−2%) | $28.27 | $625K | -9.1% | — |
| Feb 2SEC | John M. EvansCEO | Sell Plan | 16,333995,334 held (−2%) | $29.19 | $477K | -12.0% | — |
| Feb 2SEC | John M. EvansCEO | Sell Plan | 8,667986,667 held (−1%) | $29.74 | $258K | -13.6% | — |
| Feb 2SEC | John M. EvansCEO | Sell Plan | 2,906986,667 held (−0%) | $29.00 | $84K | -11.4% | — |
| Jan 26SEC | Bethany J CavanaghSvp, Finance And Treasurer | Sell Plan | 6,19834,813 held (−15%) | $35.00 | $217K | -26.6% | — |
| Jan 26SEC | Christine BellonGeneral Counsel | Sell Plan | 1,37195,667 held (−1%) | $34.00 | $47K | -24.4% | — |
| Jan 21SEC | Bethany J CavanaghSvp, Finance And Treasurer | Sell Plan | 3,03441,011 held (−7%) | $30.12 | $91K | -14.7% | — |
| Jan 20SEC | Christine BellonGeneral Counsel | Sell Plan | 15,95997,597 held (−14%) | $34.72 | $554K | -26.0% | — |
| Jan 20SEC | Christine BellonGeneral Counsel | Sell Plan | 2,111113,556 held (−2%) | $33.62 | $71K | -23.6% | — |
| Jan 20SEC | Christine BellonGeneral Counsel | Sell Plan | 55997,038 held (−1%) | $35.40 | $20K | -27.4% | — |
| Jan 5SEC | Sravan Kumar EmanyCFO | Sell Plan | 6,29473,706 held (−8%) | $27.10 | $171K | -5.2% | — |
| Jan 5SEC | Christine BellonGeneral Counsel | Sell Plan | 1,254115,667 held (−1%) | $27.10 | $34K | -5.2% | — |
| Oct 29SEC | Fmr LlcSee Remark 1 | Sell | 45914 held (−97%) | $26.68 | $12K | -3.7% | — |
| Oct 3SEC | John M. EvansCEO | Sell Plan | 25,000986,667 held (−2%) | $24.63 | $616K | +4.3% | — |
| Oct 3SEC | John M. EvansCEO | Sell Plan | 25,000986,667 held (−2%) | $24.51 | $613K | +4.9% | — |
| Oct 3SEC | Bethany J CavanaghSvp, Finance And Treasurer | Sell Plan | 46744,045 held (−1%) | $24.53 | $11K | +4.8% | — |
| Oct 3SEC | Christine BellonGeneral Counsel | Sell Plan | 373116,921 held (−0%) | $24.53 | $9K | +4.8% | — |
Insiders at Beam Therapeutics Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Fmr LlcSee Remark 1 | — | $10.1M | Jun 29, 2026 | — |
| John M. EvansCEO | — | $6.3M | Jul 1, 2026 | — |
| Giuseppe CiaramellaPresident | — | $1.4M | Apr 6, 2026 | — |
| Christine BellonGeneral Counsel | — | $881K | Apr 6, 2026 | — |
| Amy SimonChief Medical Officer | — | $607K | Jul 29, 2026 | — |
| Bethany J CavanaghSvp, Finance And Treasurer | — | $404K | Oct 2, 2026 | — |
| Sravan Kumar EmanyCFO | — | $171K | Jan 5, 2026 | — |
BEAM stock: common questions
Are Beam Therapeutics Inc. insiders buying BEAM stock?
In the past 12 months, 0 insiders reported open-market purchases of BEAM worth $0.
Are Beam Therapeutics Inc. insiders selling BEAM stock?
7 insiders reported sales worth $18.6M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is BEAM's 52-week range?
Over the past year BEAM has traded between $20.60 and $37.92. It last closed at $25.70 on Oct 9, 2026.